September 19th, 2014
Early in my career in Australia’s Flying Doctor Service, I had the privilege of providing emergency care to the rural poor. In many cases, I was able to give my patients innovative treatments that cured their ailments and improved their health and lives overall. The feelings I experienced from helping those vulnerable patients stays with me today and continues to drive me in my current role overseeing our global health portfolio of products and services for diseases of high public health impact and working with committed leaders advancing our technologies including those directed against HIV, tuberculosis, and Ebola.
Providing patients with effective treatments is the goal of every healthcare professional, scientific researcher, developer and manufacturer of new treatments and therapies. When those treatments and therapies don’t exist, there is nothing harder than looking into the eyes of your patient and their loved ones and telling them there are no options. It is their stories that compel us to do more to meet their needs by working together to bring forward new therapies.
The recent Ebola crisis and the rise in drug-resistant bacteria have forced our attention to the inadequacy of our therapeutic arsenals to address these major public health threats.